JP2011504890A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011504890A5 JP2011504890A5 JP2010535281A JP2010535281A JP2011504890A5 JP 2011504890 A5 JP2011504890 A5 JP 2011504890A5 JP 2010535281 A JP2010535281 A JP 2010535281A JP 2010535281 A JP2010535281 A JP 2010535281A JP 2011504890 A5 JP2011504890 A5 JP 2011504890A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- salt
- genitourinary disorders
- azabicyclo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07384038.1 | 2007-11-28 | ||
| EP07384038A EP2065385A1 (en) | 2007-11-28 | 2007-11-28 | Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester |
| PCT/EP2008/010012 WO2009068253A2 (en) | 2007-11-28 | 2008-11-26 | Stable crystalline salt of (r)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-yl ester |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011504890A JP2011504890A (ja) | 2011-02-17 |
| JP2011504890A5 true JP2011504890A5 (https=) | 2011-09-01 |
| JP5336509B2 JP5336509B2 (ja) | 2013-11-06 |
Family
ID=39401152
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010535281A Expired - Fee Related JP5336509B2 (ja) | 2007-11-28 | 2008-11-26 | （ｒ）−３−フルオロフェニル−３，４，５−トリフルオロベンジルカルバミン酸１−アザビシクロ［２．２．２］オクト−３−イルエステルの安定な結晶性塩 |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US8492402B2 (https=) |
| EP (2) | EP2065385A1 (https=) |
| JP (1) | JP5336509B2 (https=) |
| KR (1) | KR101557832B1 (https=) |
| CN (1) | CN101925600B (https=) |
| AU (1) | AU2008329181B2 (https=) |
| BR (1) | BRPI0819607A2 (https=) |
| CA (1) | CA2706565C (https=) |
| DK (1) | DK2220082T3 (https=) |
| EA (1) | EA017483B1 (https=) |
| ES (1) | ES2498819T3 (https=) |
| IL (1) | IL206032A (https=) |
| MX (1) | MX2010005850A (https=) |
| NZ (1) | NZ585833A (https=) |
| PL (1) | PL2220082T3 (https=) |
| UA (1) | UA102083C2 (https=) |
| WO (1) | WO2009068253A2 (https=) |
| ZA (1) | ZA201003718B (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ526580A (en) | 2000-12-22 | 2005-04-29 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as M3 antagonists |
| EP4166558A1 (en) † | 2010-02-12 | 2023-04-19 | Pfizer Inc. | Salts and polymorphs of 8-fluoro-2-{4- [(methylamino)methyl]phenyl}-1 ,3,4,5-tetrahydro-6h-azepino[5,4,3- cd]indol-6-one |
| KR101978364B1 (ko) | 2017-06-15 | 2019-05-14 | 크리스탈지노믹스(주) | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 또는 그 유도체의 약학적으로 허용 가능한 염 및 그 제조방법 |
| KR102678356B1 (ko) * | 2018-10-29 | 2024-06-26 | 씨지인바이츠 주식회사 | 알킬카바모일 나프탈렌일옥시 옥테노일 하이드록시아마이드 인산염, 타르타르산염 또는 이들의 조합을 포함하는 약제학적 조성물 및 그 제조방법 |
| US12553903B2 (en) | 2023-06-01 | 2026-02-17 | Cg Pharmaceuticals, Inc | Ivaltinostat combination therapy for treating pancreatic cancer |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE510305C2 (sv) * | 1997-05-30 | 1999-05-10 | Astra Ab | Nytt salt |
| KR100751981B1 (ko) * | 2000-06-27 | 2007-08-28 | 라보라토리오스 살바트, 에스.에이. | 아릴알킬아민으로부터 유도된 카바메이트 |
| NZ526580A (en) * | 2000-12-22 | 2005-04-29 | Almirall Prodesfarma Ag | Quinuclidine carbamate derivatives and their use as M3 antagonists |
| JP4505227B2 (ja) | 2001-12-20 | 2010-07-21 | キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ | １−アルキル−１−アゾニアビシクロ［２．２．２］オクタンカルバメート誘導体およびムスカリンレセプターアンタゴニストとしてのそれらの使用 |
| ES2203327B1 (es) * | 2002-06-21 | 2005-06-16 | Almirall Prodesfarma, S.A. | Nuevos carbamatos de quinuclidina y composiciones farmaceuticas que los contienen. |
| ES2246170B1 (es) * | 2004-07-29 | 2007-04-01 | Almirall Prodesfarma, S.A. | Nuevo procedimiento para preparar derivados de carbamato de quinuclidinio. |
-
2007
- 2007-11-28 EP EP07384038A patent/EP2065385A1/en not_active Withdrawn
-
2008
- 2008-11-26 US US12/744,493 patent/US8492402B2/en not_active Expired - Fee Related
- 2008-11-26 CN CN2008801254506A patent/CN101925600B/zh not_active Expired - Fee Related
- 2008-11-26 WO PCT/EP2008/010012 patent/WO2009068253A2/en not_active Ceased
- 2008-11-26 AU AU2008329181A patent/AU2008329181B2/en not_active Ceased
- 2008-11-26 UA UAA201007997A patent/UA102083C2/uk unknown
- 2008-11-26 NZ NZ585833A patent/NZ585833A/en not_active IP Right Cessation
- 2008-11-26 DK DK08854867.2T patent/DK2220082T3/da active
- 2008-11-26 CA CA2706565A patent/CA2706565C/en not_active Expired - Fee Related
- 2008-11-26 JP JP2010535281A patent/JP5336509B2/ja not_active Expired - Fee Related
- 2008-11-26 MX MX2010005850A patent/MX2010005850A/es active IP Right Grant
- 2008-11-26 EA EA201070651A patent/EA017483B1/ru not_active IP Right Cessation
- 2008-11-26 EP EP08854867.2A patent/EP2220082B1/en not_active Not-in-force
- 2008-11-26 ES ES08854867.2T patent/ES2498819T3/es active Active
- 2008-11-26 PL PL08854867T patent/PL2220082T3/pl unknown
- 2008-11-26 BR BRPI0819607A patent/BRPI0819607A2/pt not_active IP Right Cessation
- 2008-11-28 KR KR1020107013939A patent/KR101557832B1/ko not_active Expired - Fee Related
-
2010
- 2010-05-25 ZA ZA2010/03718A patent/ZA201003718B/en unknown
- 2010-05-27 IL IL206032A patent/IL206032A/en not_active IP Right Cessation
-
2013
- 2013-02-08 US US13/763,063 patent/US8871787B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4950896B2 (ja) | ムスカリンｍ３受容体アンタゴニストとしてのキヌクリジン誘導体およびその使用 | |
| JP2009542613A5 (https=) | ||
| JP2008518890A5 (https=) | ||
| JP2013514980A5 (https=) | ||
| JP2011504890A5 (https=) | ||
| JP2011527333A5 (https=) | ||
| JP2010500293A5 (https=) | ||
| JP2011507896A5 (https=) | ||
| JP2011505356A5 (https=) | ||
| JP2017527578A5 (https=) | ||
| JP2010077141A5 (https=) | ||
| JP2012523440A5 (https=) | ||
| JP2013541592A5 (https=) | ||
| JP2008543860A5 (https=) | ||
| JP2009534468A5 (https=) | ||
| JP2007518738A5 (https=) | ||
| JP2010514807A5 (https=) | ||
| RU2011110745A (ru) | [4-(5-аминометил-2-фторфенил)-пиперидин-1-ил]-[7-фтор-1-(2-метоксиэтил)-4-трифторметокси-1н-индол-3-ил]-метанон как ингибитор триптазы тучных клеток | |
| TWI455938B (zh) | 碳酸啶衍生物及其醫藥組成物 | |
| JP2013538849A5 (https=) | ||
| JP2010155827A5 (https=) | ||
| JP2010519300A5 (https=) | ||
| JP2010529986A5 (https=) | ||
| JP2012515150A5 (https=) | ||
| JP2013514974A5 (https=) |